![Christine B. McKinley](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Christine B. McKinley
Geen lopende functies
Loopbaan van Christine B. McKinley
Eerdere bekende functies van Christine B. McKinley
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Cell Genesys, Inc.
![]() Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Human Resources Officer | 01-08-1994 | 28-02-2009 |
Nellcor Puritan Bennett, Inc.
![]() Nellcor Puritan Bennett, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Nellcor Puritan Bennett, Inc. is a company that manufactures and supplies respiratory care products. The company is based in Pleasanton, CA. Nellcor Puritan Bennett was acquired by Mallinckrodt, Inc.(Old) on August 26, 1997 for $1,805.05 million. | Human Resources Officer | 01-01-1985 | 01-01-1994 |
Opleiding van Christine B. McKinley
University of California, Santa Barbara | Undergraduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Human Resources Officer | 2 |
Undergraduate Degree | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Cell Genesys, Inc.
![]() Cell Genesys, Inc. Pharmaceuticals: MajorHealth Technology Cell Genesys is a development-stage biotechnology firm focuses on gene-modification technologies to treat cancer. The company's lead product technology is its GVAX vaccine platform. Cell Genesys is working on GVAX vaccines for lung, prostate, and pancreatic cancer, as well as for leukemia and multiple myeloma, another blood cancer. Its oncolytic viral therapy platform uses specially engineered adenoviruses (such as the common cold) to kill cancer cells; the firm's lead candidate from this platform targets prostate cancer. | Health Technology |
Nellcor Puritan Bennett, Inc.
![]() Nellcor Puritan Bennett, Inc. Medical SpecialtiesHealth Technology Part of Medtronic Plc, Nellcor Puritan Bennett, Inc. is a company that manufactures and supplies respiratory care products. The company is based in Pleasanton, CA. Nellcor Puritan Bennett was acquired by Mallinckrodt, Inc.(Old) on August 26, 1997 for $1,805.05 million. | Health Technology |